Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
136.45
1.51 (1.12%)
At close: Aug 15, 2025, 10:15 AM

Biogen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.68B 9.84B 10.17B 10.98B
Cost of Revenue
2.31B 2.53B 2.28B 2.11B
Gross Profit
7.37B 7.3B 7.9B 8.87B
Operating Income
2.22B 2.1B 2.9B 2.84B
Interest Income
67.6M 276.5M 89.3M 11M
Pretax Income
1.91B 1.3B 3.59B 1.75B
Net Income
1.63B 1.16B 3.05B 1.56B
Selling & General & Admin
2.4B 2.5B 2.4B 2.67B
Research & Development
2.04B 2.46B 2.23B 2.5B
Other Expenses
701.1M 993.7M 358.5M 888.5M
Operating Expenses
5.15B 5.2B 4.99B 6.06B
Interest Expense
250.3M 246.9M 246.6M 253.6M
Selling & Marketing Expenses
n/a 71.4M 54.1M 98.7M
Cost & Expenses
7.46B 8B 7.27B 8.17B
Income Tax Expense
273.8M 135.3M 632.8M 52.5M
Shares Outstanding (Basic)
145.7M 144.7M 145.3M 149.1M
Shares Outstanding (Diluted)
145.9M 145.6M 146M 149.6M
EPS (Basic)
11.20 8.02 20.97 10.44
EPS (Diluted)
11.19 7.97 20.87 10.40
EBITDA
2.83B 2.38B 4.36B 3.92B
EBIT
2.16B 1.88B 3.84B 2B
Depreciation & Amortization
673.2M 494.8M 518.7M 487.3M